24/7 MN – (NASDAQ: TTOO) T2 BIOSYSTEMS, INC. shares are climbing this morning and are up 10% on more than 4500 shares.

The stocks cheap at .167 and looks to move north on news. The company announced they received FDA breakthrough designation for their panel

T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme Panel

Molecular Diagnostic Test for Early Detection of Lyme Disease


LEXINGTON, Mass., July 11, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the Company’s T2Lyme™ Panel.


Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist